EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence and diagnostic reliability of BRAF, RAS mutations, and RET/PTC rearrangements in a Latin American public health service population with thyroid nodular disease

Freddy David Moposita Molina, Grasiela Agnes, Marília Remuzzi Zandoná, Rogério Izquierdo, Fábio Alves Bilhar, Laura Berton Eidt, Virgílio Gonzales Zanella, Luiz Felipe Osowski, Sofia de Oliveira Belardinelli, Amanda Cometti de Andrade, Erika Laurini de Souza Meyer, Lenara Golbert und 1 weitere

PLOS One · 01.08.2025 · 20 (8) · e0329407

DOI: 10.1371/journal.pone.0329407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 01.08.2025. Verfasst von Freddy David Moposita Molina und 12 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Biosciences, Federal University of Health Sciences of Porto Alegre (UFCSPA), Brazil. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Thyroid Nodule, Thyroid Neoplasms, Mutation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CNPq, UFCSPA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite their high prevalence and generally benign nature in most cases, the investigation of thyroid nodules still presents potential diagnostic pitfalls, especially in cases with indeterminate cytology results. The performance of molecular markers of thyroid cancer may vary across centers and populations. This study aimed to verify the prevalence of mutations in the BRAF, and RAS genes, and RET/PTC rearrangements in patients undergoing fine-needle aspiration biopsy (FNAB) for thyroid nodule evaluation in a real-world public health service population. Point mutations and rearrangements were detected by Sanger DNA sequencing. A total of 231 thyroid nodules in 220 patients were evaluated, being 86.8% females and a mean age of 55.6 ± 13.9 years. For molecular analysis, high-quality DNA and RNA were obtained from 200 samples. Mutations or rearrangements in target genes were identified in 14% of the 200 samples evaluated. The frequency of the BRAF -like mutations was 5.5%, detected in 9 out of 17 malignant nodules (52.9%) and one in a benign nodule (0.7%). Fourteen RAS- like mutations were identified in benign nodules (57.1% HRAS , 21.5% NRAS and 21.5% KRAS ) and only one was present in a malignant nodule (5.9%). Considering only nodules with indeterminate cytology (Bethesda III and IV, n = 53), 9 mutations were detected, 6 in benign histology (all RAS -like), 1 in malignant histology ( BRAF- like), and 2 still unoperated, therefore without a histopathological diagnosis. This research concludes that the presence of the BRAF V600E mutation could be useful in supporting the diagnosis of thyroid cancer, due to its high positive predictive value, since 89% of nodules with BRAF V600E mutation were malignant. Additionally, clinical criteria should be established to determine which nodules with RAS -like mutations require closer follow-up, particularly those with indeterminate cytology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins B-rafThyroid NoduleThyroid NeoplasmsMutationProto-Oncogene Proteins c-retGene RearrangementHumansFemaleMaleMiddle AgedAdultAgedPrevalenceBiopsy, Fine-NeedleThyroid Cancer, PapillaryReproducibility of Results

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, humanProto-Oncogene Proteins c-retRET protein, human

Autor:innen und Institutionen

  • Graduate Program in Biosciences, Federal University of Health Sciences of Porto Alegre (UFCSPA), Brazil.
  • Molecular Biology Laboratory, UFCSPA, Brazil.
  • Radiology Unit, Santa Casa de Porto Alegre, Brazil.
  • Endocrine Unit, Hospital Nossa Senhora da Conceição, Grupo Hospitalar Conceição, Brazil.
  • Endocrine Unit, Santa Casa de Porto Alegre, Brazil.
  • Head and Neck Unit, Santa Casa de Porto Alegre, Brazil.

ORCID-Profile: Vanessa Suñé Mattevi

Förderung

  • CNPq
  • UFCSPA

Zitieren

APA

Moposita Molina, F. D., Agnes, G., Zandoná, M. R., Izquierdo, R., Bilhar, F. A., Eidt, L. B., Zanella, V. G., Osowski, L. F., Belardinelli, S. O., de Andrade, A. C., de Souza Meyer, E. L., Golbert, L., & Suñé Mattevi, V. (2025). Prevalence and diagnostic reliability of BRAF, RAS mutations, and RET/PTC rearrangements in a Latin American public health service population with thyroid nodular disease. PLOS One, 20(8), e0329407. https://doi.org/10.1371/journal.pone.0329407

Vancouver

Moposita Molina FD, Agnes G, Zandoná MR, Izquierdo R, Bilhar FA, Eidt LB, et al. Prevalence and diagnostic reliability of BRAF, RAS mutations, and RET/PTC rearrangements in a Latin American public health service population with thyroid nodular disease. PLOS One. 2025;20(8):e0329407. doi:10.1371/journal.pone.0329407

BibTeX
@article{MopositaMolina2025,
  author = {Moposita Molina, Freddy David and Agnes, Grasiela and Zandoná, Marília Remuzzi and Izquierdo, Rogério and Bilhar, Fábio Alves and Eidt, Laura Berton and Zanella, Virgílio Gonzales and Osowski, Luiz Felipe and Belardinelli, Sofia de Oliveira and de Andrade, Amanda Cometti and de Souza Meyer, Erika Laurini and Golbert, Lenara and Suñé Mattevi, Vanessa},
  title = {Prevalence and diagnostic reliability of BRAF, RAS mutations, and RET/PTC rearrangements in a Latin American public health service population with thyroid nodular disease},
  journal = {PLOS One},
  year = {2025},
  volume = {20},
  number = {8},
  pages = {e0329407},
  doi = {10.1371/journal.pone.0329407}
}
Kostenlos starten →